Business Post Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Post Examiner.

Press releases published on July 8, 2026

2 hours ago

Snail Games 推出《方舟：創世崛起》第一部分、《方舟：財富之潮》及《方舟：龍之烏托邦》可下載內容；遞延收入積壓中的 1,100 萬美元將於 2026 年第三季度確認

Indeterminate GlobeNewswire

2 hours ago

Pune and Gurgaon Appliance Rentals Rise as ₹18,000–₹45,000 Purchase Costs and Repair Bills Push Households Toward ₹149/Month Plans From Rentomojo

Indeterminate GlobeNewswire

2 hours ago

Vivani Medical schließt Vereinbarung mit Novo Nordisk zur Evaluierung von NPM-139, einem miniaturisierten, ultra-langwirkenden Semaglutid-Implantat zur langfristigen Gewichtsregulierung

Indeterminate GlobeNewswire

2 hours ago

Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité

Indeterminate GlobeNewswire

2 hours ago

Vivani Medical Mengadakan Perjanjian dengan Novo Nordisk untuk Mengevaluasi NPM-139, Implan Semaglutide Miniatur dengan Kerja Sangat Panjang untuk Pengelolaan Berat Badan Kronis

Indeterminate GlobeNewswire

2 hours ago

ヴィヴァニ・メディカル、慢性体重管理のためのセマグルチドの超長時間作用小型インプラント「NPM-139」の評価に向け、ノボ ノルディスクと契約を締結

Indeterminate GlobeNewswire

2 hours ago

Vivani Medical, 만성 체중관리용 초장기 지속형 세마글루타이드 임플란트 'NPM-139' 평가 위해 Novo Nordisk와 계약 체결

Indeterminate GlobeNewswire

2 hours ago

Vivani Medical Menandatangani Perjanjian dengan Novo Nordisk bagi Menilai NPM-139, Implan Semaglutide Miniatur dengan Tindakan Ultra Jangka Panjang bagi Pengurusan Berat Badan Kronik

Indeterminate GlobeNewswire

2 hours ago

Vivani Medical เข้าทำข้อตกลงกับ Novo Nordisk เพื่อประเมิน NPM-139…

Indeterminate GlobeNewswire

2 hours ago

Vivani Medical 与 Novo Nordisk 达成协议，评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139

Indeterminate GlobeNewswire

2 hours ago

Vivani Medical 與 Novo Nordisk 達成協議，評估一種微型、超長效並用於慢性體重管理的司美格魯肽植入劑 NPM-139

Indeterminate GlobeNewswire

3 hours ago

Zillow Group Securities Fraud Class Action Arising from Alleged Anticompetitive Agreement and Related Regulatory Risks – Investors May Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC

Indeterminate GlobeNewswire

3 hours ago

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Indeterminate GlobeNewswire

3 hours ago

FuelCell Energy Announces Upsize and Pricing of Offering of Common Stock

Indeterminate GlobeNewswire

3 hours ago

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Indeterminate GlobeNewswire

3 hours ago

Via Transportation, Inc. Securities Class Action Result of Undisclosed Growth Obstacles and approximately 70% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Indeterminate GlobeNewswire

3 hours ago

Sportradar Securities Fraud Class Action Result of Compliance Misrepresentations and 22% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Indeterminate GlobeNewswire

3 hours ago

AeroVironment, Inc. Notice of July 27, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Indeterminate GlobeNewswire

3 hours ago

PicS N.V. Notice of August 4, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

Indeterminate GlobeNewswire

3 hours ago

Hub Group, Inc. Securities Fraud Class Action Result of Erroneous Financial Statements and approximately 31% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Indeterminate GlobeNewswire